Urine Drug Testing among Opioid-Naïve and Long-Term Opioid Nevada Medicaid Beneficiaries

2020 ◽  
Vol 55 (14) ◽  
pp. 2314-2320
Author(s):  
Sarah Friedman ◽  
Kirtan Patel ◽  
Yan Liu ◽  
Sarah Hartzell ◽  
Michelle S. Keller
JAMA Oncology ◽  
2020 ◽  
Vol 6 (4) ◽  
pp. 580 ◽  
Author(s):  
Joseph Arthur ◽  
Zhanni Lu ◽  
Kristy Nguyen ◽  
David Hui ◽  
Bernard Prado ◽  
...  

2017 ◽  
Vol 76 ◽  
pp. 36-42 ◽  
Author(s):  
Katie L. Miller ◽  
Brandi L. Puet ◽  
Ali Roberts ◽  
Cheryl Hild ◽  
Jason Carter ◽  
...  

2014 ◽  
Vol 30 (8) ◽  
pp. 679-684 ◽  
Author(s):  
Gary M. Reisfield ◽  
Karen J. Maschke

Author(s):  
Shaden A. Taha ◽  
Jordan R. Westra ◽  
Mukaila A. Raji ◽  
Yong F. Kuo

2021 ◽  
Vol 14 (6) ◽  
pp. e241311
Author(s):  
Minnan Al-Khafaji ◽  
Sabina Podbicanin ◽  
Deep Ghaghda ◽  
Saajan Basi ◽  
Shuja Punekar

A 45-year-old Caucasian man was admitted to hospital following a collapse at home. On admission, this patient was noted to have a Glasgow Coma Scale (GCS) Score of 9 out of 15, fever and tachypnoea. The patient was identified to have bilateral limb weakness, predominately on the left side, with associated dysphagia. Radiological imaging demonstrated bilateral multifocal intracranial haemorrhage and subarachnoid haemorrhage. Neurosurgical input was sought; the outcome of this was a decision to manage the patient conservatively, without surgical intervention. Of note, his urine drug testing revealed a positive result for a cocktail of drugs including cocaine, benzoylecgonine (cocaine metabolite), methadone, heroin, norbuprenorphine and benzodiazepine. Throughout the admission, the patient was monitored in an intensive care setting. The patient received support with feeding, speech and mobilisation. The patients’ GCS improved throughout the admission. Following a 30-day admission, the patient walked home.


1988 ◽  
Vol 34 (3) ◽  
pp. 471-473 ◽  
Author(s):  
M A Peat

Abstract Many laboratories are now performing urine drug testing for employers, governmental agencies, and other institutions. It is now recognized that presumptive positive screening results have to be confirmed by an analytical procedure based on a different chemical technique with greater than or equal sensitivity to the screening test. Thin-layer chromatography has been widely used for this; however, it is relatively insensitive for certain drugs, and it cannot satisfy the accuracy and precision requirements needed to determine threshold concentrations reliably. Gas chromatography-mass spectrometry is able to satisfy these threshold requirements and has become the method of choice for confirming initial immunoassay results.


2017 ◽  
Vol 52 (8) ◽  
pp. 497-506 ◽  
Author(s):  
N. N. Stephanson ◽  
P. Signell ◽  
A. Helander ◽  
O. Beck

Sign in / Sign up

Export Citation Format

Share Document